{"name":"Center for International Blood and Marrow Transplant Research","slug":"center-for-international-blood-and-marrow-transplant-research","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE84SU8ycDFVWjExMkZ0MDdObVZNdll5Nk5oNG4yU0xrX1hyME81bGtNeGpMM1hIdmFIQ0xQQnVWanZETUpkTnByRnhHSUtaYlBtVDdYeFFUeG1najZH?oc=5","date":"2026-02-20","type":"pipeline","source":"EurekAlert!","summary":"Hidden genetic mismatch, which triples the risk of a life-threatening immune attack after cord blood transplantation - EurekAlert!","headline":"Hidden genetic mismatch, which triples the risk of a life-threatening immune attack after cord blood transplantation - E","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxPTk05bHlEUXZ1NkdrNDh4OTh3RWt2TjQ2MVlrU2lmb05KRHkzaGtDbFlNZjREQzUyLXp3NFlmUDNaVnRtY2JqX1JSRkE0WkYyS1VkbWJQU0dvVXRUNi1DZ2JFSF9BeUktNG4tU05UVk1YR2tsVVVfWjJHTzVVUXY2TVR5d1RlRGowQWdrd3Q0cURFMExsOE94WjRxaEJUdG10Vk5ISk9xbFFXOEZHeU0zcEo5OGszcnhueGZxS2JtX2F0UW9iaTFNcjh3VkxqYlhKQ2YxYWVEZFNqeWxTZjhDazFzVlh5YUdaSzNlRjQySjQ3Q3hFVFZ5OE5HRG1MT2VtcU9wTnAxdEF1VW9mTGp5eHBR?oc=5","date":"2026-02-09","type":"trial","source":"Business Wire","summary":"Estrella Immunopharma Presents Promising Updated Data on EB103 in Oral Presentation at the 2026 Tandem Meetings of ASTCT® & CIBMTR® - Business Wire","headline":"Estrella Immunopharma Presents Promising Updated Data on EB103 in Oral Presentation at the 2026 Tandem Meetings of ASTCT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxOcE92QWhRbTVnQmdiYzl2Mlp2VHl6a1ZJbkdXQl9zVXJrSm5xOU9YemFkUjMwOHJJckdGVkhCOXhDdDNKdEVtSHVULUt2MHZiOGlTTm8xMi0yTlR0N1Z6RVdrM1ZfcE1xQTlZbllhU3hrZl9zRFhfQW1vOVNodVdaS0o4Y2M3Mm9BSjFrWUdaXzFHVElKNS1sR3NmTlRyQ3JWZEFQcDNYeXlxY2JJWWtna0JqM2lOWTNHVlROMGxzdmZDZ1FfcEpzTW9NVGEyUmhNak0tOG9BZlBPMjdPWHlDTlpkajJwOUtDYTZLSFlScFhMOU1jY1BsLWhmVG9ISkdQMnJLYXdZR2lxV3doU21ZdjZJZ3RRcEt0TVlfRS1ONUxMSGVVRUNyRjBB?oc=5","date":"2026-02-03","type":"trial","source":"Business Wire","summary":"Estrella Immunopharma Announces Late-Breaking Oral Presentation of Phase 1 STARLIGHT-1 Data for EB103 at the 2026 Tandem Meetings of ASTCT® & CIBMTR® - Business Wire","headline":"Estrella Immunopharma Announces Late-Breaking Oral Presentation of Phase 1 STARLIGHT-1 Data for EB103 at the 2026 Tandem","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTFB1dWlqR2lkZ2VyeV8yQXhyMzFfQkdkeGQ4V2xzeF81Y25DQXVacVEzcXg4YVRmMENaUW9TX3FpeGdGQjg5QXRHaG5oaUxJUUNBS04yYkx6VWpEYmR6cVdWRkV6MA?oc=5","date":"2025-08-11","type":"pipeline","source":"Wiley Online Library","summary":"CD19 CAR T-Cell Therapy for Primary Mediastinal Large B-Cell Lymphoma: A CIBMTR Analysis - Wiley Online Library","headline":"CD19 CAR T-Cell Therapy for Primary Mediastinal Large B-Cell Lymphoma: A CIBMTR Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE0xc0ZoTGxyeUROLUlQTjBBZVRQUGZrRlppZEJyV2pBTWJzdTlOY0xQREJDeUZtNENOVV96Z2I4RTZqYlI5djlUWmk4cHEzdWhHVXRJS1NUTzdtV1pKa1c0NVNBanVkQ29l?oc=5","date":"2025-07-22","type":"pipeline","source":"Wiley Online Library","summary":"Chimeric antigen receptor T‐cell therapy for high‐grade B‐cell lymphoma NOS - Wiley Online Library","headline":"Chimeric antigen receptor T‐cell therapy for high‐grade B‐cell lymphoma NOS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE5Iem42U0hidW9HMlRHNEFiMTFIUkxvd05GUkVCUjZWSmJLaVFJN2ZIMW1jdEZPWER4NUV2cG82YTEwNDkzMVowRFU4RnM2cHNTY01TdU1tWVhsdzZZd0stSTBKSQ?oc=5","date":"2025-05-19","type":"pipeline","source":"Wiley Online Library","summary":"Classical and Late-Onset SOS/VOD After Allogeneic HSCT: A Japanese Transplant Registry Analysis - Wiley Online Library","headline":"Classical and Late-Onset SOS/VOD After Allogeneic HSCT: A Japanese Transplant Registry Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE85LWhoVXA5SC1NbDM2cmRBN0Ixa1hLVzIyeklZWjlWOWtWTWkxU1k3WjJhRXRRU0JZNHgyZEc3NlJvOWlSNG9lR1hhUkVpSWRvY1Myb05WVEZ3c3JiT1NF?oc=5","date":"2025-04-17","type":"pipeline","source":"Nature","summary":"The impact of the SARS-CoV-2 pandemic on umbilical cord blood transplantation in Japan: insights from an interrupted time series analysis | Bone Marrow Transplantation - Nature","headline":"The impact of the SARS-CoV-2 pandemic on umbilical cord blood transplantation in Japan: insights from an interrupted tim","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5hMkdWUnBWbEdOV0tLS0JiM0VoaTUzVjJWV1EwdzZnTURHeUlLcHU5SE1KSGUzT2dhQXBZR1NiSGFUaUJnNUYtTkFQaWRIR2ZKME8xd1g4dTB0dUN6YThF?oc=5","date":"2024-03-05","type":"regulatory","source":"Nature","summary":"Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the","headline":"Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chime","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE81WWF5VmNmdWhZbmthWmxBUzFReGlacHFNMkxaTklJb3dCclFIaldGRHZmYlJESGdzUjF2YmU0SWpiaTRKLVljUWlUNTFfdGlZVEV1Z2JVQQ?oc=5","date":"2023-06-01","type":"regulatory","source":"Haematologica","summary":"Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy - Haema","headline":"Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one ye","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxPQ3NlNlc5eDFCdG80b3VicFA4NFhON0ppTDczN3dlWWtPUE9iazcxWlA2TndaaHdKU2xUVnRrOGthN0VGc2pvdHZoMTI4MGdONkFZR0YtZml2VmQ1Z0NESVVfRmh6MktOcTF6VkZnXzRDcWxJUUdsWmNqNjRYWFlheEo4TWptX3pXd1lyYVlaV2J0eEM1aGVHTG1SS2ZpTUlGZmhFUmxXMXJmSTBOWWVKeURya1lTNjAzdGVZZllIVE56MDhpbmZwcFg4VjV0N3h0TVhIU1RLVUR5dEk?oc=5","date":"2023-03-09","type":"trial","source":"PR Newswire","summary":"Astellas and BMT CTN Announce Topline Results from Phase 3 MORPHO Trial of Gilteritinib - PR Newswire","headline":"Astellas and BMT CTN Announce Topline Results from Phase 3 MORPHO Trial of Gilteritinib","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNQVVnNnVncWpjeDBNdHV2UWRORjh5eFZiTXhqb0tqSS1aRlZQTy13TFVzUDJ6SG5DTWtod2VMQnFBWTRvSHBlMW50QUMxeV9sLVVreXVra0xEQ0hPVHpkbmZGZGZwaXphR0hYejVEOVloaWVCT2ZQZ0JhZm9taDF4c0pMQ1dYdHNRYUxWVkdrSldUUnRScHhPR1prUEFuRERLQ1VVUTZVVmEzMFpyMmdjLTA3Nk9FTWdBWFhYV2pRVTJsb2x0U1ZSREpwM05mdw?oc=5","date":"2023-02-21","type":"pipeline","source":"statnews.com","summary":"Antibody treatment benefits leukemia patients receiving bone marrow transplant - statnews.com","headline":"Antibody treatment benefits leukemia patients receiving bone marrow transplant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxOMUhkWTlKM2RKTnZ6cTdud1BYQmtVeGZzaEpNYVJiSzM4ZDYwUHM3d2pXWUE2T2RiT0xHNXdrWHhuOHVjT1JUQVpXcnlzMHFJT0ZmNWF1LVZqWl9zRE1mVkpoX3pERnRVTm94S2FITkpvQ3dDQzlqaTZiSlpPWHBRakVyRkZXOVRfSVpLQzdJOG9aanFZLTVmSGEtdkVvcXBsUlVxV1ROejRLM0pvcmhVbUs2YkdoOXVDMi1iMXpDbGJVWV8tMGVYRndtZkFQd0JWYl9pdGRuZGZrRmpwQ3d2V0VSVQ?oc=5","date":"2020-12-25","type":"trial","source":"The ASCO Post","summary":"Transplant May Improve Survival in Older Patients With High-Risk Myelodysplastic Syndrome, Study Reports - The ASCO Post","headline":"Transplant May Improve Survival in Older Patients With High-Risk Myelodysplastic Syndrome, Study Reports","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}